Home Salipro Biotech

Salipro Biotech

In operation
-
Pharmaceutical R&D Developer

Basic Information

Salipro Biotech Develops Nanoparticles to Increase the Solubility of Hydrophobic Substances.Unlocking challenging drug targets for the development of next-generation therapies, most drug targets are so-called membrane proteins, which are inherently unstable and difficult to study. Our proprietary Salipro® technology stabilizes membrane proteins in their native form, enabling their use in drug discovery for therapeutic antibodies or small molecule drugs, thereby driving the discovery of new medicines.
Salipro Biotech AB
Stockholm,Stockholm,Sweden
less than 15 people
January 01, 2016
--